$1.03
-0.32 (-23.70%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,733.0% upside
Low Target
$17.82
Average Target
$29.18
High Target
$40.31
Current Price
$1.03
Current
$1.03
$1.03
Target
$29.18
$29.18
$17.82
$29.18 avg
$40.31
Scenario Analysis
Bear Case
$17.82
1,630.1%
Low target
Base Case
$29.18
+2,733.0%
Avg target
Bull Case
$40.31
+3,813.6%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$5.14
-80.0% from high
52-Week Low
$0.82
+25.6% from low
Target vs 52W High
$29.18
+467.7% vs high
Next Earnings Report
Aug 13, 2026 · After Market Close
4d
until earnings
EPS Est: $-0.53
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |